The AMR Studio

Uppsala Antibiotic Center

The AMR Studio is a podcast dedicated to the current multidiciplinary research on antimicrobial resistance, hosted by the Uppsala Antibiotic Center. The AMR Studio podcast is co-led by Eva Garmendia & Elin Fermér.

  1. 2025-12-15

    Ep 63: Enrico Baraldi & antibiotics' markets. Colonization of the microbiome. 2025 GLASS report.

    We hear a lot about the need for new antibiotics. But what about the ones we already have? In this episode, we sit down with Enrico Baraldi to explore the hidden world behind antibiotic markets. You hear how supply chains break, why withdrawals happen, and what it really takes to keep essential drugs available in countries like Sweden. You also get a look at the methods behind this research, the collaborations that make it possible, and some misconceptions that still shape the policy conversation. What happens when economic models, healthcare needs, and global responsibilities collide? This conversation opens that door. On our news section, we first cover a recent publication exploring the factors determining the colonization of the microbiome by antibiotic-resistant E. coli bacteria, and we bring an overview of the much-awaited Global Antibiotic Resistance Surveillance Report for 2025. We wish you a peaceful and rewarding winter break, and see you again in the new year! Check relevant links in the show notes here. ⁠ Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    1 tim 4 min

  2. 2025-10-20

    Ep X13: Antibiotic Resistance & Cancer

    A child in remission. A sudden fever. The antibiotics stop working. In this episode at The AMR Studio we dive into the hidden link between cancer and antibiotic resistance: why cancer patients are especially vulnerable, how antibiotics in oncology affect resistance, and what researchers are doing to change it. In this episode, communications intern Jose Rodriguez Capel, bring us the connection between microbiology, oncology, and patient stories in a powerful way. Check the episode transcript and relevant links in the show notes here https://www.uu.se/en/centre/uppsala-antibiotic-center/communication/the-amr-studio/episode-x13 . Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    14 min

  3. 2025-06-23

    Ep 62: Tove Fall, the microbiome & study design. The vaginal resistome. Metallo-beta-lactamase inhibitors.

    Happy start of the summer, dear listeners! In this episode before our break, we interview Professor Tove Fall, a veterinarian turned epidemiologist working to unveil the molecular connections determining health and sickness. We learn about her path, how she developed her career to fit her interests and strong skills, and how important study design is. In the news section we cover a recent review about the vaginal microbiota, and a publication from one of our PhD students, who has been working on developing a new kind of inhibitor for metallo beta lactamases. We hope you enjoy this episode! Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    1 tim 9 min

  4. 2025-05-12

    Ep 61: Elias Arnér, redox & EbsArgent. Ceftazidime-avibactam for P. aeruginosa treatment. FusB-mediated resistance.

    In this episode, we bring you an interview with Professor Elias Arnér from the Karolinska Institute. After a long international career in redox biology, Professor Arnér became CEO of Thioredoxin Systems, the company behind a potential new antibiotic with a novel target and mode of action: EbsArgent. We explore his background, the lessons he has learned, and what makes this new drug candidate so unique. In the news section, Elin brings us a recent article on the resistance and potential collateral sensitivity of Ceftazidime-avibactam to treat P. aeruginosa strains. Eva shares the latest publication at our center, with PhD student Adrián González López’s work on the mechanisms behind FusB-mediated resistance in Staphylococcus aureus. We hope you enjoy this month’s episode, and see you on the next one! Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    1 tim 8 min

  5. 2025-04-07

    Ep 60: Till Bachmann & providing solutions for AMR. AI to help tackle AMR. Horizontal gene transfer drivers.

    Welcome to episode 60th! YES, 60!! Celebrate this rounded number with us and Prof. Till Bachmann in an inspiring interview where we learn Till’s journey, explore how diagnostics are an essential part of managing AMR and infection treatment, and revisit the DOSA project. This multidisciplinary & one-health-focused multi-country endeavor provides solutions to a neglected disease: UTI. In the news section, we cover a recent review looking at the current uses of AI in the field of AMR and how it can help us better tackle different fronts, like diagnostics, surveillance, or antibiotic development. We also bring you the latest publication by the CARe center in Gothenburg, where they show that an AI model can predict successful horizontal gene transfer leading to resistance, and what drives these events. We hope you enjoy this episode! Check relevant links in the show notes here ⁠https://www.uu.se/en/centre/uppsala-antibiotic-center/communication/the-amr-studio/episode-60. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    1 tim 8 min

  6. 2025-03-03

    Ep 59: Vance Fowler & the Antibacterial Resistance Leadership Group. Pipeline for studying AMR in pig farms. Commentary on public involvement.

    Welcome to a new episode of The AMR Studio! This month, we bring you an interview with MD Dr. Vance Fowler, co-lead of the Antibacterial Resistance Leadership Group (a.k.a. ARLG). In our chat, we learn how Dr. Fowler came into AMR, the decades-long work they’ve been doing with MRSA research, and the ins and outs of the ARLG. In the news section, we proudly present the recent published paper by our PhD student Valeriia Ladyhina, who has worked on optimizing a pipeline to ease the work to study AMR dynamics in pig farms. We also cover a recent commentary on public involvement for AMR, and an AMR journal collection. Thank you for being with us one more month! Check relevant links in the show notes here . Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    56 min

  7. 2025-02-03

    Ep 58: Evangelos Mourkas, campylobacter & urbanization. Probiotics & AMR. Plasmid-chromosome cross-talk.

    Welcome to 2025! We are so happy to be starting one more year with you, our 8th year! On this episode, we bring you the story and work of Dr. Evangelos Mourkas, a veterinarian-turned-computational biologist who loves to also do the field work himself! In this interview, we dive deep into his motivators, reflections, and how campylobacter can be used as a marker for AMR spread. On the news section, we bring you a recent paper looking into the potential risks of probiotics through the lens of AMR, and the latest publication by a previous guest, Alvaro San Millán, exploring the cross-talk between plasmids and the carrier’s chromosome. We hope you enjoy this month’s content and are ready to share an awesome 2025 of learning and exploring new themes! Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    1 tim 5 min

  8. 2024-12-03

    Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance.

    Hitting this November month with a very relevant topic, Global Governance! In this episode, you can listen to an interview with had with Prof. Olivier Rubin, from Roskilde University in Denmark, about the social dimensions of AMR, and how AMR is a so-called “creeping crisis” globally. Olivier has years of experience researching slow-onset crisis such as famine and climate change, and has in the recent years worked intensively in AMR and the similarities and differences with such crises. Tune in to hear his insights! In the news section, we update you on our very very busy month of November, and bring you a really important paper demonstrating the relationship between rifaximin use and daptomicin resistance in Enterococcus. Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

    1 tim 9 min
Visa alla (77)

Betyg och recensioner

5
av 5
6 betyg

Om

The AMR Studio is a podcast dedicated to the current multidiciplinary research on antimicrobial resistance, hosted by the Uppsala Antibiotic Center. The AMR Studio podcast is co-led by Eva Garmendia & Elin Fermér.

Information

  • Skapad av
    Uppsala Antibiotic Center
  • Aktiva år
    2018 - 2025
  • Avsnitt
    77
  • Åldersgräns
    Vuxet innehåll
  • Copyright
    © Uppsala Antibiotic Center
  • Programmets webbplats
    The AMR Studio

Du kanske också gillar